Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families

Takayo Arisato, Ryuichi Okubo, Hitoshi Arata, Koji Abe, Kei Fukada, Saburo Sakoda, Akira Shimizu, Xing Hui Qin, Shuji Izumo, Mitsuhiro Osame, Masanori Nakagawa

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

We clarified the clinical and pathological aspects of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R heterozygous mutation in the Miyakonojo Basin, a region in southern Japan where the prevalence of ALS is 11.4 per 105 of the population. We studied 17 patients, including one autopsy case, in three FALS families with the mutation. The average age at disease onset in the families was 44.3±8.7 years, and the mean disease duration was 12±7.6 years, with a range of 6 to 30 years. Ten of 17 patients were unable to walk by the mean age of 56.4±12.2 years. The initial symptom was muscle weakness in the distal leg muscle in all patients. The autopsy findings of one FALS patient showed atrophy of lateral and anterior funiculi, decreased numbers of anterior horn cells, preserved posterior funiculus and absence of neuronal inclusion bodies. Percentages of mutant SOD1 protein measured by mass spectrometry were 14% in erythrocytes, 43% in the spinal cord, 47% in the iliopsoas muscle and 60% in the diaphragm. In this study, we confirmed that FALS with SOD1 H46R mutation showed uniform initial symptoms and slow disease progression with intrafamilial variation of disease severity and that inclusion body formation is not essential in FALS with this mutation.

Original languageEnglish
Pages (from-to)561-568
Number of pages8
JournalActa Neuropathologica
Volume106
Issue number6
DOIs
Publication statusPublished - Dec 2003

Fingerprint

Mutation
Inclusion Bodies
Autopsy
Anterior Horn Cells
Muscles
Muscle Weakness
Mutant Proteins
Diaphragm
Age of Onset
Atrophy
Disease Progression
Mass Spectrometry
Leg
Spinal Cord
Japan
Erythrocytes
Amyotrophic lateral sclerosis 1
Clinical Studies
Population

Keywords

  • Autopsy case
  • Clinical course
  • FALS
  • Mutant protein
  • SOD1 H46R mutation

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families. / Arisato, Takayo; Okubo, Ryuichi; Arata, Hitoshi; Abe, Koji; Fukada, Kei; Sakoda, Saburo; Shimizu, Akira; Qin, Xing Hui; Izumo, Shuji; Osame, Mitsuhiro; Nakagawa, Masanori.

In: Acta Neuropathologica, Vol. 106, No. 6, 12.2003, p. 561-568.

Research output: Contribution to journalArticle

Arisato, T, Okubo, R, Arata, H, Abe, K, Fukada, K, Sakoda, S, Shimizu, A, Qin, XH, Izumo, S, Osame, M & Nakagawa, M 2003, 'Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families', Acta Neuropathologica, vol. 106, no. 6, pp. 561-568. https://doi.org/10.1007/s00401-003-0763-5
Arisato, Takayo ; Okubo, Ryuichi ; Arata, Hitoshi ; Abe, Koji ; Fukada, Kei ; Sakoda, Saburo ; Shimizu, Akira ; Qin, Xing Hui ; Izumo, Shuji ; Osame, Mitsuhiro ; Nakagawa, Masanori. / Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families. In: Acta Neuropathologica. 2003 ; Vol. 106, No. 6. pp. 561-568.
@article{59d4517b993b414b8cee03ffb7301ff2,
title = "Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families",
abstract = "We clarified the clinical and pathological aspects of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R heterozygous mutation in the Miyakonojo Basin, a region in southern Japan where the prevalence of ALS is 11.4 per 105 of the population. We studied 17 patients, including one autopsy case, in three FALS families with the mutation. The average age at disease onset in the families was 44.3±8.7 years, and the mean disease duration was 12±7.6 years, with a range of 6 to 30 years. Ten of 17 patients were unable to walk by the mean age of 56.4±12.2 years. The initial symptom was muscle weakness in the distal leg muscle in all patients. The autopsy findings of one FALS patient showed atrophy of lateral and anterior funiculi, decreased numbers of anterior horn cells, preserved posterior funiculus and absence of neuronal inclusion bodies. Percentages of mutant SOD1 protein measured by mass spectrometry were 14{\%} in erythrocytes, 43{\%} in the spinal cord, 47{\%} in the iliopsoas muscle and 60{\%} in the diaphragm. In this study, we confirmed that FALS with SOD1 H46R mutation showed uniform initial symptoms and slow disease progression with intrafamilial variation of disease severity and that inclusion body formation is not essential in FALS with this mutation.",
keywords = "Autopsy case, Clinical course, FALS, Mutant protein, SOD1 H46R mutation",
author = "Takayo Arisato and Ryuichi Okubo and Hitoshi Arata and Koji Abe and Kei Fukada and Saburo Sakoda and Akira Shimizu and Qin, {Xing Hui} and Shuji Izumo and Mitsuhiro Osame and Masanori Nakagawa",
year = "2003",
month = "12",
doi = "10.1007/s00401-003-0763-5",
language = "English",
volume = "106",
pages = "561--568",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families

AU - Arisato, Takayo

AU - Okubo, Ryuichi

AU - Arata, Hitoshi

AU - Abe, Koji

AU - Fukada, Kei

AU - Sakoda, Saburo

AU - Shimizu, Akira

AU - Qin, Xing Hui

AU - Izumo, Shuji

AU - Osame, Mitsuhiro

AU - Nakagawa, Masanori

PY - 2003/12

Y1 - 2003/12

N2 - We clarified the clinical and pathological aspects of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R heterozygous mutation in the Miyakonojo Basin, a region in southern Japan where the prevalence of ALS is 11.4 per 105 of the population. We studied 17 patients, including one autopsy case, in three FALS families with the mutation. The average age at disease onset in the families was 44.3±8.7 years, and the mean disease duration was 12±7.6 years, with a range of 6 to 30 years. Ten of 17 patients were unable to walk by the mean age of 56.4±12.2 years. The initial symptom was muscle weakness in the distal leg muscle in all patients. The autopsy findings of one FALS patient showed atrophy of lateral and anterior funiculi, decreased numbers of anterior horn cells, preserved posterior funiculus and absence of neuronal inclusion bodies. Percentages of mutant SOD1 protein measured by mass spectrometry were 14% in erythrocytes, 43% in the spinal cord, 47% in the iliopsoas muscle and 60% in the diaphragm. In this study, we confirmed that FALS with SOD1 H46R mutation showed uniform initial symptoms and slow disease progression with intrafamilial variation of disease severity and that inclusion body formation is not essential in FALS with this mutation.

AB - We clarified the clinical and pathological aspects of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R heterozygous mutation in the Miyakonojo Basin, a region in southern Japan where the prevalence of ALS is 11.4 per 105 of the population. We studied 17 patients, including one autopsy case, in three FALS families with the mutation. The average age at disease onset in the families was 44.3±8.7 years, and the mean disease duration was 12±7.6 years, with a range of 6 to 30 years. Ten of 17 patients were unable to walk by the mean age of 56.4±12.2 years. The initial symptom was muscle weakness in the distal leg muscle in all patients. The autopsy findings of one FALS patient showed atrophy of lateral and anterior funiculi, decreased numbers of anterior horn cells, preserved posterior funiculus and absence of neuronal inclusion bodies. Percentages of mutant SOD1 protein measured by mass spectrometry were 14% in erythrocytes, 43% in the spinal cord, 47% in the iliopsoas muscle and 60% in the diaphragm. In this study, we confirmed that FALS with SOD1 H46R mutation showed uniform initial symptoms and slow disease progression with intrafamilial variation of disease severity and that inclusion body formation is not essential in FALS with this mutation.

KW - Autopsy case

KW - Clinical course

KW - FALS

KW - Mutant protein

KW - SOD1 H46R mutation

UR - http://www.scopus.com/inward/record.url?scp=10744229692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744229692&partnerID=8YFLogxK

U2 - 10.1007/s00401-003-0763-5

DO - 10.1007/s00401-003-0763-5

M3 - Article

VL - 106

SP - 561

EP - 568

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 6

ER -